Literature DB >> 8720135

Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay.

M Seki1, Y Honda.   

Abstract

Phosphorothioate antisense oligodeoxynucleotides (S-ODNs) designed to hybridize to the 5' region of the hepatitis C virus (HCV) genome were evaluated as to their ability to inhibit HCV gene expression, using an in vitro translation system. Three effective regions were found to interfere with the translation of HCV RNAs. These regions were region A [nucleotides (nt) 124 to 153], region B (nt 100 to 123), and region C (nt 324 to 360). Further detailed evaluation of S-ODNs within each region allowed us to propose some HCV-specific antiviral agent candidates. Two of them, SMS16 (nt 328 to 347) and SMS17 (nt 326 to 345), caused over 90% inhibition of HCV gene expression when present in a less than fourfold molar excess; this effect was sequence-specific and dose-dependent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8720135     DOI: 10.1093/oxfordjournals.jbchem.a125007

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.

Authors:  Peter A C 't Hoen; Ruud Out; Jan N M Commandeur; Nico P E Vermeulen; F H D van Batenburg; Muthiah Manoharan; Theo J C van Berkel; Erik A L Biessen; Martin K Bijsterbosch
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

2.  Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation.

Authors:  Béatrice Tallet-Lopez; Lydia Aldaz-Carroll; Sandrine Chabas; Eric Dausse; Cathy Staedel; Jean-Jacques Toulmé
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

3.  In vitro inhibition of hepatitis C virus by antisense oligonucleotides in PBMC compared to hepatoma cells.

Authors:  Samar Samir Youssef; Ahmed Mohamed Fahmy; Moataza Hassan Omran; Amr Saad Mohamed; Mohamed Ali El Desouki; Mostafa K El-Awady
Journal:  Biomed Res Int       Date:  2014-06-01       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.